- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2014-005541-50.
Displaying page 1 of 1.
EudraCT Number: 2014-005541-50 | Sponsor Protocol Number: ESP1/SARC025 | Start Date*: 2016-09-13 | |||||||||||||||||||||
Sponsor Name:Sarcoma Alliance for Research through Collaboration (SARC) | |||||||||||||||||||||||
Full Title: ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor, Niraparib and Temozolomide and/or Irinotecan in Patients with Previously Treated, incurable Ewing Sarcoma | |||||||||||||||||||||||
Medical condition: relapsed Ewing sarcoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
